Results 161 to 170 of about 6,799 (258)

The Non-Canonical ChREBPα Activity Suppresses the Activation of Hepatic Stellate Cells and Liver Fibrosis by Antagonizing TGF-β-E2F1 Axis. [PDF]

Adv Sci (Weinh)
Zhang J, Zhao Y, Pulivendala G, Zhang Q, Rui L, Gao J, Wang H, Zhang G, Nuotio-Antar A, Tong X, Yin L.   +10 more
europepmc   +1 more source

Impact of cystic fibrosis transmembrane conductance regulator modulator therapies on liver stiffness and liver enzymes: An observational perspective single‐center cohort study

JPGN Reports, EarlyView.
Abstract Objectives The efficacy of cystic fibrosis transmembrane conductance regulator (CFTR)‐modulator therapies in preventing or ameliorating cystic fibrosis liver disease (CFLD) by correcting CFTR in cholangiocytes is not well‐documented. This study aimed to assess liver function during CFTR‐modulators.
Laura Giugliano, Elisabetta Augustoni, Antonio Pizzol, Anna Opramolla, Cristina Chiadò, Anna Zagaria, Irene Esposito, Giulia Roberto, Alice Ponte, Andrea Evangelista, Paola Quarello, Michele Pinon, Pier Luigi Calvo   +12 more
wiley   +1 more source

Rapid-Onset Drug-Induced Liver Injury Following Amoxicillin-Clavulanate: A Case Report. [PDF]

Clin Case Rep
Khadka S, Dev A, Yadav PS, Acharya S, Karki A, Shah L.   +5 more
europepmc   +1 more source

Fate and effects of Nodularia spumigena and its toxin, nodularin, in Baltic Sea planktonic food webs [PDF]

, 2006
Karjalainen, Miina
core  

Control and management of harmful algal blooms [PDF]

, 2015
Barrington, DJ, Coggins, LX, Ghadouani, A, Xi, X   +3 more
core   +1 more source

The effects of royal jelly on human health: A narrative review of clinical studies

JSFA reports, EarlyView.
Abstract Royal jelly (RJ) is a natural bioactive substance with documented effects on human health. This narrative review synthesizes evidence from clinical and clinically relevant experimental studies evaluating the therapeutic potential of RJ.
Goras Georgios, Thrasyvoulou Andreas, Tsilimpokou Evanthia   +2 more
wiley   +1 more source

Alcohol use disorder: an Australian perspective on screening, diagnosis, treatment and prevention. [PDF]

Intern Med J
Palmer AJ, Connor JP, Clark PJ.
europepmc   +1 more source

You Dropped the Bomb on Me: A Case Series of Carbon Tetrachloride Toxicity. [PDF]

Cureus, 2023
Stashin AR, Fikse DJ, Orta AM, Briggs RP, Wheatley SM, Koons AL.   +5 more
europepmc   +1 more source

Metabolic Dysfunction‐Associated Steatotic Liver Disease and Obesity: Pathogenesis, Diagnostics, Risk Stratification, and Therapeutic Approach

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Metabolic dysfunction‐associated steatotic liver disease (MASLD) has emerged as the most prevalent chronic liver disease worldwide, closely linked to the global rising incidence of obesity and metabolic syndrome. This review synthesizes current evidence on the pathogenesis, gut–liver axis, and multidisciplinary management of MASLD within the ...
Beom Kyung Kim
wiley   +1 more source

CD8 T Cell Hyperfunction and Reduced Tumour Control in Murine Models of Advanced Liver Disease. [PDF]

Eur J Immunol
Madani J, Li J, Ching MEA, Vranjkovic A, Jorritsma K, Hasim MS, Daneshmand M, Campeau N, Lawton DA, Bagheri S, Cheung AC, Mulvihill EE, Bruin JE, Ardolino M, Crawley AM.   +14 more
europepmc   +1 more source